Get the Stockscreener App
3.42
2.09%
0.07
Mdxhealth Sa stock is traded at $3.42, with a volume of 166.24K.
It is up +2.09% in the last 24 hours and down -3.39% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
See More
Previous Close:
$3.35
Open:
$3.36
24h Volume:
166.24K
Relative Volume:
1.30
Market Cap:
$175.67M
Revenue:
$63.69M
Net Income/Loss:
$-44.82M
P/E Ratio:
-1.71
EPS:
-2
Net Cash Flow:
$-30.56M
1W Performance:
-3.12%
1M Performance:
-3.39%
6M Performance:
-3.12%
1Y Performance:
+108.54%
1-Day Range:
$3.29
$3.49
1-Week Range:
$3.26
$3.75
52-Week Range:
$1.35
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
3.42 | 172.07M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | Craig Hallum | Buy |
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
BTIG reiterates MDxHealth stock rating on strong volume growth By Investing.com - Investing.com Canada
BTIG reiterates MDxHealth stock rating on strong volume growth - Investing.com
MDxHealth SA (MDXH.BR) Competitors - Meyka
Moving Averages: Whats the RSI of MDxHealth SA stockJuly 2025 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Short Interest Down 23.1% in February - MarketBeat
Returns Recap: What are MDxHealth SAs earnings expectationsWeekly Risk Report & Verified Short-Term Trading Plans - baoquankhu1.vn
MDXH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Mdxhealth Q4 2025 revenue up 19% to USD 29.5M - Medical Buyer
MDxHealth ADR earnings missed by $0.04, revenue fell short of estimates - Investing.com Australia
MDXH Should I Buy - Intellectia AI
MDxHealth SA (MDXH) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
MDxHealth (NASDAQ:MDXH) Announces Earnings Results - MarketBeat
MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
MDxHealth (MDXH) Q4 2025 Earnings Call Transcript - The Globe and Mail
MDxHealth Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: MDxHealth misses Q4 2025 expectations, stock steady - Investing.com
MDXH Exceeds Revenue Expectations with Strong Q4 Performance - GuruFocus
MDxHealth SA reports results for the quarter ended December 31Earnings Summary - TradingView
MDxHealth Delivers 20% 2025 Revenue Growth and Names Interim CFO Ron Kalfus - TipRanks
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results | Associated Press | syndication news - Enidnews.com
Cancer-test maker Mdxhealth narrows 2025 loss, guides 27-30% growth for 2026 - Stock Titan
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results - Bitget
Dow Update: Should I invest in MDxHealth SA before earningsTrade Entry Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Given Average Rating of “Moderate Buy” by Analysts - Defense World
MDxHealth SA (NASDAQ:MDXH) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Will MDxHealth SA stock benefit from infrastructure spendingPortfolio Update Report & Free Growth Oriented Trading Recommendations - mfd.ru
MDxHealth (MDXH) Projected to Post Quarterly Earnings on Thursday - MarketBeat
[EFFECT] MDxHealth SA SEC Filing - Stock Titan
Medtronic Just Posted Its Best Quarter in 2.5 Years - AOL.com
Aug Outlook: Should I invest in MDxHealth SA before earningsQuarterly Trade Report & Expert Curated Trade Ideas - baoquankhu1.vn
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth to Release Q4 and Full Year 2025 Financial Results on February 26, 2026, Followed by Conference Call - Quiver Quantitative
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewswire Inc.
Bond Watch: Whats the RSI of MDxHealth SA stock2025 Top Gainers & Expert-Curated Trade Recommendations - baoquankhu1.vn
Can MDxHealth SA stock continue upward trendWeekly Loss Report & Stock Portfolio Risk Management - mfd.ru
MDxHealth Details Exosome Diagnostics Deal and Restructured GPS Earnout Obligations - TipRanks
MDxHealth (MDXH) outlines ExoDx acquisition terms and GPS earnout changes - Stock Titan
Trading Action: Should I invest in MDxHealth SA before earningsJuly 2025 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Aug Shorts: Can Xcel Energy Inc disrupt its industryTrend Reversal & Real-Time Stock Entry Alerts - baoquankhu1.vn
Trend Recap: Whats the RSI of MDxHealth SA stockGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
Analysts Expect Breakeven For MDxHealth SA (NASDAQ:MDXH) Before Long - Sahm
MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - MarketBeat
Retail Surge: How interest rate cuts could boost MDxHealth SA stockSwing Trade & Community Trade Idea Sharing Platform - Bộ Nội Vụ
MDxHealth Posts Preliminary 2025 Results, Expects Revenue Growth Of 26% To 28% In 2026 - Nasdaq
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance By Investing.com - Investing.com India
MDxHealth Sees Over 20% Revenue Growth in Q4, Full Year - Orange County Business Journal
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance - Investing.com
MDXH Projects Strong Revenue Growth and Ambitious 2026 Targets - GuruFocus
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):